
Varex Imaging (VREX) Stock Forecast & Price Target
Varex Imaging (VREX) Analyst Ratings
Bulls say
Varex Imaging Corp has demonstrated a strong recovery in sales, particularly from the Chinese market, with approximately $35 million generated in the first fiscal quarter of 2025, indicating a rebound in higher-margin tube sales. The company's proactive approach to mitigating supply chain risks through diversification of material sources and global manufacturing capabilities supports its operational stability and growth potential. Additionally, positive cash flow of $9.5 million and strong liquidity, with $345 million in cash against $566 million in debt, further enhance the financial outlook for the company as it capitalizes on increasing demand for border security and cargo inspection systems.
Bears say
Varex Imaging Corp's financial outlook reflects challenges stemming from ongoing trade tensions, particularly between the U.S. and China, which significantly affect its revenue from that region, accounting for about 15% of total revenues. The company's first-quarter revenues for fiscal year 2025 amounted to $200 million, a decline of 2.9% sequentially, indicating difficulties in maintaining revenue momentum and compounded by underperformance in key markets such as radiography, oncology, and dental sectors. Additionally, the uncertain tariff landscape and higher costs associated with importing materials have further complicated Varex's operational efficiency and revenue generation capabilities, contributing to a cautious revenue forecast for the upcoming second quarter.
This aggregate rating is based on analysts' research of Varex Imaging and is not a guaranteed prediction by Public.com or investment advice.
Varex Imaging (VREX) Analyst Forecast & Price Prediction
Start investing in Varex Imaging (VREX)
Order type
Buy in
Order amount
Est. shares
0 shares